Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ImmuPharma plc (LSE: IMM)

 
IMM Technical Analysis
5
As on 4th Feb 2025 IMM STOCK Price closed @ 5.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.87 & Strong Buy for SHORT-TERM with Stoploss of 1.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IMMSTOCK Price

Open 5.02 Change Price %
High 5.60 1 Day -0.10 -1.96
Low 5.00 1 Week 0.95 23.46
Close 5.00 1 Month 3.72 290.62
Volume 4408316 1 Year 2.77 124.22
52 Week High 5.90 | 52 Week Low 0.85
 
LSE UK Most Active Stocks
MSMN 0.04 0.00%
VOD 65.10 -7.03%
EME 0.16 6.67%
SMDS 582.50 0.00%
DKE 0.15 0.00%
PREM 0.02 0.00%
RRR 0.04 0.00%
NNN 0.09 50.00%
TRP 0.03 0.00%
DMTR 0.03 0.00%
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
SSIF 18.50 208.33%
CGW 55.03 107.66%
GILD 0.08 100.00%
GILD 0.08 100.00%
GILD 0.08 100.00%
CNN 65.00 85.71%
VENC 139.60 65.21%
0UTC 0.41 51.85%
NNN 0.09 50.00%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
IMM
Daily Charts		 IMM
Intraday Charts		 Whats New @
Bazaartrend		 IMM
Free Analysis
 
IMM Important Levels Intraday
RESISTANCE6.16
RESISTANCE5.79
RESISTANCE5.56
RESISTANCE5.33
SUPPORT4.67
SUPPORT4.44
SUPPORT4.21
SUPPORT3.84
 
IMM Forecast February 2025
Share
4th UP Forecast6.35
3rd UP Forecast5.92
2nd UP Forecast5.65
1st UP Forecast5.38
1st DOWN Forecast4.62
2nd DOWN Forecast4.35
3rd DOWN Forecast4.08
4th DOWN Forecast3.65
 
IMM Weekly Forecast
4th UP Forecast6.14
3rd UP Forecast5.77
2nd UP Forecast5.55
1st UP Forecast5.32
1st DOWN Forecast4.68
2nd DOWN Forecast4.45
3rd DOWN Forecast4.23
4th DOWN Forecast3.86
 
IMM Forecast2025
4th UP Forecast17.47
3rd UP Forecast13.47
2nd UP Forecast11
1st UP Forecast8.53
1st DOWN Forecast1.47
2nd DOWN Forecast-1
3rd DOWN Forecast-3.47
4th DOWN Forecast-7.47
 
 
IMM Other Details
Segment EQ
Market Capital 17590536.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IMM Address
IMM
 
IMM Latest News
 
Your Comments and Response on ImmuPharma plc
 
IMM Business Profile
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity, metabolism, anti-infectives, and cancer. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidate includes IPP-204106, a peptide to modulate angiogenesis with application in cancer and ophthalmology; and BioGlucagon a therapy for low sugar events in diabetes. ImmuPharma plc has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom. Address: 1 Bartholomew Close, London, United Kingdom, EC1A 7BL
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service